Click on image to view larger version.

Fig. 3. Effect of
- and ß-adrenergic antagonists on p38-MAPK
stimulation by phenylephrine (PHE). (A) p38-MAPK phosphorylation was assessed
by western immunoblotting in samples (100 µg of protein) from control
Rana ridibunda hearts and hearts perfused with 50 µmol
l-1 PHE in the presence or absence of 1 µmol l-1
prazosin (PZ) (Ai), 1 µmol l-1 phentolamine (PHT) (Aii), 1
µmol l-1 yohimbine (YOH) (Aiii) and 1 µmol l-1
propranolol (PRO) (Aiv). Western blot analysis was performed as described in
Materials and methods. Identical samples were also assayed for total p38-MAPK
immunoreactivity (B). Each experiment was repeated on two further occasions
with similar results. Bands were quantified by laser scanning densitometry and
plotted (C). Asterisks indicate values significantly different from controls:
*P<0.05, **P<0.01.